World Nausea Medicine Market is Projected to Grow at a CAGR over 7.2% from 2017 to 2023

(IT-NEWSWIRE.COM, October 24, 2017 )
Nausea Medicine Market Information: By Type (Antacids, Antagonists), Mode of Administration (IV, Tablets), Indication (GERD, Chemotherapy), Indication (Gastroenteritis, Gastric Ulcer), End User (Hospitals, Clinics, Pharmaceutical Companies) - Global Forecast till 2023

Nausea is a distress in stomach with involuntary urge to vomit which may be due to number of indications such as gastrointestinal diseases such as stomach upset, gastric ulcers. Furthermore, chemotherapy induced nausea is less common than other symptoms such as gastric reflux. Nausea is found to be common among children and pregnant women.
The global Nausea Medicine Market is expected to grow at a CAGR of 7.2% during the forecast period.
Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Nausea Medicine market research report–Global forecast till 2023.”
Get a sample report at https://www.marketresearchfuture.com/sample_request/4523 .
Major Players in Nausea Medicine Market:
Some of the key players in the global market are Merck & Co., Inc. (U.S.), Sanofi (France), TESARO, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer (U.S.), GlaxoSmithKline (U.S.), ANI Pharmaceuticals, Inc. (U.S.).
Regional Analysis
America rules the global nausea medicine market due to rising prevalence of nausea among pregnant women and children in the U.S and Latin America. Furthermore, availability of medicines for the treatment of nausea and rising awareness about the contraindications and safe use of medicines market also boost the market growth.
Europe acquires the second position in the market owing to rising prevalence of viral gastroenteritis. According to an article published in the journal of Clinical Virology, in Europe, acute infectious gastroenteritis is one of the major causes for substantial morbidity and economic loss.
Asia Pacific is the fastest growing market for nausea medicine due to lifestyle changes and unhealthy diet. Furthermore, prevalence of viral gastritis is also found to increasing. In Asia Pacific, the common cause of severe gastroenteritis in children less than 5 years of age, is rotavirus. The market in Asia Pacific is driven by an increasing demand for rapid diagnostics tests for gastrointestinal diseases and increasing awareness about available treatment options for viral gastroenteritis. Also, growing investments in the field of life science research and demand for advanced therapies for the treatment of nausea in developing nations such as China and India will propel the growth of the Asia Pacific market.
The market is Middle East & Africa is expected to show positive growth owing to an increase in the number of gastrointestinal problems such gastritis. Chemotherapy induced nausea is found to be prevalent in this region inducing the market growth.
Segmentation
The global nausea medicine market is segmented on the basis of type, mode of administration, indication, and end user.
On the basis of type, market is segmented into antacids, antagonists, anti-anxiety drugs, steroids, cannabinoids and others. Antacids are further segmented into serotonin (5-HT3) antagonists, NK-1 antagonists, and dopamine antagonists.
On the basis of mode of administration, the market is segmented into IV, tablets, and others.
On the basis of indication, the market is segmented into gastroesophageal reflux disease (GERD), viral gastroenteritis, motion sickness and seasickness, medication, chemotherapy, and others.
On the basis of end user, the market is segmented into hospitals, clinics, pharmaceutical companies, and others.
Browse complete report at https://www.marketresearchfuture.com/reports/nausea-medicine-market-4523 .
Nausea is a state of stomach distress with an urge to vomit. Common indications of nausea are motion sickness, seasickness, medication and chemotherapy. Stomach ulcers can also cause nausea. Medications and proper dietary habits can treat nausea.
Rising prevalence of gastrointestinal diseases, such as Gastroesophageal Reflux Disease (GERD), and viral gastroenteritis, and availability of a wide range of treatment options drive the market growth. Furthermore, changing lifestyle and dietary habits also influence the market.
The global nausea medicine market is expected to grow at a CAGR of 7.2% during the forecast period.
Europe is the second largest market for nausea medicine which exhibits growth opportunities owing to the high prevalence of nausea and vomiting among pregnant women whose population is found to be increasing. Furthermore, there is an extensive demand for the diagnosis and treatment of nausea, especially among pregnant women which will influence the market growth in Europe. Additionally, prevalence of chemotherapy induced nausea is found to be increasing steadily in many parts for the Europe in the last few years. This will further increase the demand for nausea medicine in Europe.
In Asia Pacific, the market is expected grow at the fastest rate owing to changing lifestyle and increasing geriatric population fuel the market growth. Furthermore, viral gastritis and gastric ulcer are found to be prevalent among the Asian Population. However, presence of misbranded and spurious drugs may restrain the market growth in Asia Pacific.
The Middle East & Africa also show a steady rise in the market owing to rising prevalence of chemotherapy induced nausea.
Ask Question to Expert at https://www.marketresearchfuture.com/enquiry/4523
Table Of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Contact:
Akash Anand
Market Research Future
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: Akash.Anand@Marketresearchfuture.Com
Web: Https://Www.Marketresearchfuture.Com

Marketresearchfuture

Market Research Future

+1 (646) 845 9349

sales@wiseguyreports.com

Source: EmailWire.Com

Source: EmailWire.com

Technology News & Search Engine

World Nausea Medicine Market is Projected to Grow at a CAGR over 7.2% from 2017 to 2023